Last reviewed · How we verify

NCT03775616

Financial Navigation Program Intervention in Supporting Patients With Solid Tumors and Their Caregivers

Completed NA Last updated 20 May 2019
What this trial tests

NA trial testing Educational Intervention in Caregiver in 30 participants. Completed in 15 May 2019.

Timeline
15 November 2017
Primary endpoint
15 May 2019
15 May 2019

Quick facts

Lead sponsorFred Hutchinson Cancer Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment30
Start date15 November 2017
Primary completion15 May 2019
Estimated completion15 May 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Fred Hutchinson Cancer Center — full company profile →

Who can join

18 and older, any sex, with Caregiver or Solid Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial studies how well a financial navigation program intervention works in supporting patients with solid tumors and their caregivers. The financial navigation program intervention is an educational course about cancer treatment cost. This educational course may provide cancer patients and their caregivers with helpful information about dealing with cancer treatment cost.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Educational Intervention

Trials testing the same drug.

Other recruiting trials for Caregiver

Currently open trials in the same condition.

Other Fred Hutchinson Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03775616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing